The pupillary response test as a method to differentiate various types of dementia;Der rezeptortest bei der pupillometrie als methode zur differenzierung des dementiellen syndroms

Neuropsychiatrie

Volumn 23, Issue 1, 2009, Pages 52-57

  Grünberger, Josef ^a   Prause, Wolfgang ^a   Frottier, Patrick ^b   Stöhr, Hans ^a   Saletu, Bernd ^a   Haushofer, Manfred ^c   Rainer, Michael ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Justizanstalt Wien Mittersteig ^*  (Austria)

^c Memory Klinik   (Austria)

Author keywords

Dementia; Differential diagnosis; Pupillometry; Receptor test; Tropicamide

Indexed keywords

TROPICAMIDE; DIAGNOSTIC AGENT; EYE DROPS; MUSCARINIC RECEPTOR BLOCKING AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; AUSTRIA; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; PUPIL REFLEX; PUPILLOMETRY; CLASSIFICATION; DRUG EFFECT; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; SIGNAL PROCESSING;

AGED; ALZHEIMER DISEASE; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MUSCARINIC ANTAGONISTS; NEUROPSYCHOLOGICAL TESTS; OPHTHALMIC SOLUTIONS; PREDICTIVE VALUE OF TESTS; REFLEX, PUPILLARY; SIGNAL PROCESSING, COMPUTER-ASSISTED; TROPICAMIDE;

EID: 66149093073     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ferri CP., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M.: Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112-2117 (2005).
2. Folstein M.F., Folstein S.E., McHugh P.R.: "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198 (1975).
3. Granholm E., Morris S., Galasko D., Shults C., Rogers E., Vukov B.: Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease. Int J Psychophysiol 47, 95-115 (2003). (Pubitemid 36149746)
4. Grünberger J., Linzmayer L., Grünberger M., Saletu B.: Pupillometry in clinical psychophysiological diagnostics: methodology and proposals for application in psychiatry. Isr J Psychiatry Relat Sci 29, 100-113 (1992).
5. Grünberger J., Linzmayer L., Walter H., Rainer M., Masching A., Pezawas L., Saletu-Zyhlarz G.M., Stöhr H., Grünberger M.: Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease. Neuropsychobiology 40, 40-46 (1999).
6. Grünberger J.: Pupillometrie in der klinisch-psychophysiologischen Diagnostik. Springer, Wien, New York (2003).
7. Higuchi S., Matsushita S., Hasegawa Y., Muramatsu T., Arai H.: Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia. Exp Neurol 144, 199-201 (1997).
8. Higuchi S., Matsushita S., Hasegawa Y., Muramatsu T., Arai H., Hayashida M.: Apolipoprotein E epsilon 4 allele and pupillary response to tropicamide. Am J Psychiatry 154, 694-696 (1997). (Pubitemid 27197608)
9. Hou R.H., Samuels E.R., Raisi M., Langley R.W., Szabadi E., Bradshaw C.M.: Why patients with Alzheimer's disease may show increased sensitivity to tropicamide eye drops: role of locus coeruleus. Psychopharmacology (Berl) 184, 95-106 (2006). (Pubitemid 43005762)
10. Houlden H., Crook R., Backhovens H., Prihar G., Baker M., Hutton M., Rossor M., Martin J.J., Van Broeckhoven C., Hardy J.: ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. Am J Med Genet 81, 117-121 (1998). (Pubitemid 28114860)
11. Idiaquez J., Alvarez G., Villagra R., San Martin R.A.: Cholinergic supersensitivity of the iris in Alzheimers disease. J Neurol Neurosurg Psychiatry 57, 1544-1545 (1994).
12. Iijima A., Haida M., Ishikawa N., Ueno A., Minamitani H., Shinohara Y.: Reevaluation of tropicamide in the pupillary response test for Alzheimer's disease. Neurobiol Aging 24, 789-796 (2003). (Pubitemid 37288854)
13. Dilling H. (Hrsg): Internationale Klassi- fikation psychischer Störungen: ICD-10, Kapitel V (F); klinisch-diagnostische Leitlinien. 5. Aufl. Huber, Bern 2005.
14. Kardon R.H.: Drop the Alzheimer's drop test. Neurology 50, 588-591 (1998).
15. Alf C., Bancher C., Benke T., Berek K., Bertha G., Bodner T., Croy A., Dal-Bianco P., Fazekas F., Fischer P., Fruhwürth G., Gatterer G., Hinterhuber H., Imarhiagbe D., Krautgartner M., Jaksch A., Jellinger K., Kalousek M., Ladurner G., Leblhuber F., Lechner A., Lingg A., Marksteiner J., Nakajima T., Psota G., Rainer M., Ransmayr G., Reisecker F., Rumpl E., Schmidt R., Walch T., Walter A., Wancata J.: Konsensusstatement "Demenz" der Österreichischen Alzheimer Gesellschaft und Österreichischen Alzheimer Liga zur Demenz. Neuropsychiatrie, 18, 39-46 (2004).
16. Litvan I., FitzGibbon E.J.: Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects? Neurology 47, 1324-1326 (1996).
17. Prettyman,R., Bitsios P., Szabadi E.: Altered pupillary size and darkness and light reflexes in Alzheimer's disease. J Neurol Neurosurg Psych 62, 665-668 (1997). (Pubitemid 27281280)
18. Robles A., Tourino R., Gude F., Noya M.: The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia. Funct Neurol 14, 203-207 (1999). (Pubitemid 30197734)
19. Saunders A.M., Schmader K., Breitner J.C., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., et al.: Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342, 710-711 (1993). (Pubitemid 23279765)
20. Scinto L.F., Daffner K.R., Dressler D., Ransil B.I., Rentz D., Weintraub S., Mesulam M., Potter H.: A potential noninvasive neurobiological test for Alzheimer's disease. Science 266, 1051-1054 (1994). (Pubitemid 24373724)
21. Scinto L.F., Rentz D.M., Potter H., Daffner K.R.: Pupil assay and Alzheimer's disease: a critical analysis. Neurology 52, 673-674 (1999).
22. Scinto L.F., Wu C.K., Firla K.M., Daffner K.R., Saroff D., Geula C.: Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease. Acta Neuropathol (Berl) 97, 557-564 (1999). (Pubitemid 29231673)
23. Scinto L.F.: ApoE allelic variability influences pupil response to cholinergic challenge and cognitive impairment. Genes Brain Behav (Epup) Jun 8 (2006).
24. Shulman K., Shedletsky R., Silver I.: The challenge of time. Clock drawing and cognitive function in the elderly. Int J Geriatr Psychiatry 1, 135-140 (1986).
25. Treloar A.J., Assin M., Macdonald A.J.: Pupillary response to topical tropicamide as a marker for Alzheimer's disease. Br J Clin Pharmacol 41, 256-257 (1996). (Pubitemid 26079187)
26. Wancata J., Kaup B., Krautgartner M.: Projections in the incidence of dementia in Austria for the years 1951 to 2050. Wien Klin Wochenschr 113, 172-80 (2001).